Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group-Reference-Cited by-同舟云学术

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

Published:2013-02-25 Issue:4 Volume:54 Page:541-548
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Yanik Gregory A.,Parisi Marguerite T.,Shulkin Barry L.,Naranjo Arlene,Kreissman Susan G.,London Wendy B.,Villablanca Judith G.,Maris John M.,Park Julie R.,Cohn Susan L.,McGrady Patrick,Matthay Katherine K.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference40 articles.

1. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions

2. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

3. Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma (HR-NB): a Children's Oncology Group (COG A3973) study;Kreissman;J Clin Oncol.,2007

4. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

5. Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodality imaging of bone marrow involvement in paediatric oncology;EJC Paediatric Oncology;2024-12

2. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining 123I-MIBG SPECT-CT radiomics and clinical factors;Pediatric Radiology;2024-03-16

3. Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer;Indian Journal of Cancer;2024-01

4. Pediatric Abdominal Tumors: Neuroblastoma;Evidence-Based Imaging;2024

5. Metastatic Disease Burden;Pediatric Oncology;2024